[Autoimmune thrombocytopenia and pregnancy]

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Immunology

Context:

• Idiopathic thrombocytopenic purpura (ITP) affects approximately 1 in 5000 pregnancies.
• Maternal risks are minimal with appropriate management.
• Fetal thrombocytopenia can occur due to maternal anti-platelet antibodies crossing the placenta.

Purpose:

• To outline diagnostic and management strategies for ITP in pregnancy.
• To highlight the risks of fetal hemorrhage, particularly intracranial hemorrhage.
• To discuss the limitations of maternal platelet counts and antibody levels in predicting fetal outcomes.

Summary:

• Fetal scalp blood sampling at labor onset is crucial for assessing fetal platelet counts.
• A fetal platelet count above 50 X 10(9)/L allows for safe vaginal delivery.
• Counts below this threshold necessitate a prophylactic Cesarean section.

Impact:

• Improved fetal surveillance and management of ITP in pregnancy.
• Reduced incidence of fetal hemorrhage during delivery.
• Potential for in utero fetal treatment via cord blood sampling and ultrasound-guided interventions.